SCHEMBL72538

SCHEMBL72538

N=C1CCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL195302 0.97
Ammonia Solution, Strong SCHEMBL20547687 0.97
Hydrochloric Acid SCHEMBL3725636 0.94
SCHEMBL1062238 0.90
SCHEMBL15310709 0.88 INMT (0.32)
Hydrochloric Acid SCHEMBL6380144 0.88
SCHEMBL11036759 0.65
SCHEMBL13228784 0.63
SCHEMBL9381198 0.62
SCHEMBL889760 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 19048 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747409-A2 COLLECTION, ASSESSMENT AND EARLY DETECTION OF HUMAN LUNG CANCER BIOMARKERS IN EXHALED BREATH CONDENSATES OF MOUSE ANIMAL MODELS Hackensack Meridian Health, Inc. (US) 2026-05-27 EP claimed
CN-122075683-A Lipid nanoparticle for in vivo generation of chimeric antigen receptor neutrophils, preparation method and application thereof 2026-05-26 CN claimed
CN-122006676-A Nanoparticle for enriching low-abundance protein in blood plasma, preparation method thereof and application thereof in early cancer screening 中国科学院长春应用化学研究所 2026-05-12 CN claimed
EP-4719485-A1 ANTIBODY-DRUG CONJUGATES FOR TREATING INFECTIONS OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) Taimed Biologics Inc. (TW) 2026-04-08 EP claimed
US-20260060999-A1 REINFORCEMENT OF MUCUS BARRIER PROPERTIES Cirqle Biomedical Contraception Ivs (DK) 2026-03-05 US claimed
EP-4661854-A1 METHODS FOR PREPARING AN ACTIVE LAYER AND DEVICES COMPRISING SAME Epitomee Medical Ltd. (IL) 2025-12-17 EP claimed
WO-2025227262-A1 IMMOBILIZED ENZYMES FOR THE BIOELECTRIC PRODUCTION OF FORMATE AND FORMIC ACID ANODYNE CHEMISTRIES, INC. (CA) 2025-11-06 WO claimed
EP-4642491-A1 METHOD FOR GLYCOPROTEIN MODIFICATION Honeybear Biosciences Inc. (TW) 2025-11-05 EP claimed
EP-3897735-B1 BIOLOGICALLY ACTIVE CLUSTER OF MOLECULES SAPREME TECH BV (NL) 2025-10-22 EP claimed
EP-4626957-A1 MODIFIED GELATINS, HYDROGELS, AND PROCESSES FOR THEIR PRODUCTION Gelomics Pty Ltd (AU) 2025-10-08 EP claimed
WO-1987002251-A1 ORAL DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES BOUND TO VITAMIN B12, OR ANALOGUES THEREOF BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) 1987-04-23 WO claimed
US-4608246-A Testing for a blood group immunological reaction IMMUCOR, INC. (US) 1986-08-26 US claimed
EP-0184710-A2 Magnetic microspheres BAYER AG (DE) 1986-06-18 EP claimed
EP-0157797-A1 DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) IMMUCOR, INC. (US) 1985-10-16 EP claimed
EP-0057140-B1 THIOLATED POLYPEPTIDIC COMPOUND FROM A TETANIC TOXIN FRAGMENT, PROCESS FOR ITS PRODUCTION AND ITS APPLICATIONS INSTITUT PASTEUR (FR) 1985-07-17 EP claimed
WO-1985001354-A1 DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) IMMUCOR, INC. (US) 1985-03-28 WO claimed
EP-0030496-B1 THIOLATED POLYPEPTIDIC COMPOUND COMING FROM A FRAGMENT OF TETANIC TOXINE, PROCESS FOR OBTAINING IT AND ITS APPLICATIONS INSTITUT PASTEUR (FR) 1983-07-13 EP claimed
EP-0057140-A2 Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications INSTITUT PASTEUR (FR) 1982-08-04 EP claimed
EP-0030496-A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications INSTITUT PASTEUR (FR) 1981-06-17 EP claimed
US-4263277-A APPLYING ALKALINE SOLUTION TO HAIR AMERICAN CYANAMID COMPANY (US) 1981-04-21 US claimed